Mckesson (MCK) Capital Expenditures Growth (3y) (2012 - 2026)
Mckesson (MCK) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 9.09% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 17.21% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 10.23% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -6.92% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 15.98% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -24.06% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.09% |
| Dec 31, 2025 | 33.72% |
| Sep 30, 2025 | 2.79% |
| Jun 30, 2025 | 39.07% |
| Mar 31, 2025 | 44.68% |
| Dec 31, 2024 | -29.69% |
| Sep 30, 2024 | 88.56% |
| Jun 30, 2024 | -2.59% |
| Mar 31, 2024 | 28.59% |
| Dec 31, 2023 | -23.62% |
| Sep 30, 2023 | 32.50% |
| Jun 30, 2023 | 0.74% |
| Mar 31, 2023 | -21.98% |
| Dec 31, 2022 | -31.04% |
| Sep 30, 2022 | 85.80% |
| Jun 30, 2022 | -30.66% |
| Mar 31, 2022 | 15.87% |
| Dec 31, 2021 | 6.89% |
| Sep 30, 2021 | -29.48% |
| Jun 30, 2021 | -13.22% |